Fund profile · Compiled from public sources

Finchley Healthcare Ventures

North America, null · Seed → Series B

Their stated focus (public profile)

Finchley Healthcare Ventures invests in emerging companies developing novel drug therapies aimed at addressing significant unmet medical needs, with a focus on reaching proof of concept in humans across any disease inadequately served by current treatments. They are interested in a broad range of modalities including small molecules, antibodies, and breakthrough technologies such as nanotechnologies. They also invest in life sciences venture capital funds to access a diverse range of opportunities. The fund has no geographical restrictions and supports portfolio companies through affiliated service companies in bioanalytical, CDMO, and specialty pharmaceutical areas.

Stages: Seed → Series B

Sectors: Healthtech, Life sciences, Deep tech

On file: 4 partners on record

Website: finchleyventures.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →